Mini Review
Published on 16 Aug 2024
Recent approaches of antibody therapeutics in androgenetic alopecia
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1434961
- 1,656 views
Type at least 3 characters
1,645 articles
Articles
Original Research
Published on 16 Aug 2024
Human adipose mesenchymal stem cell-derived exosomes alleviate fibrosis by restraining ferroptosis in keloids
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431846
- 1,123 views
Original Research
Published on 15 Aug 2024
PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1442876
- 1,032 views
Review
Published on 13 Aug 2024
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1450558
- 1,337 views
Review
Published on 05 Aug 2024
Role and mechanisms of autophagy, ferroptosis, and pyroptosis in sepsis-induced acute lung injury
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415145
- 2,008 views
- 1 citation
Original Research
Published on 01 Aug 2024
Oleanane triterpenoids with C-14 carboxyl group from Astilbe grandis inhibited LPS-induced macrophages activation by suppressing the NF-ÎşB signaling pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413876
- 902 views
Original Research
Published on 01 Aug 2024
A risk-scoring system to predict dupilumab-associated ocular surface disease in patients with atopic dermatitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1425550
- 1,050 views
Original Research
Published on 31 Jul 2024
N-demethylsinomenine metabolite and its prototype sinomenine activate mast cells via MRGPRX2 and aggravate anaphylaxis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389761
- 943 views
Mini Review
Published on 26 Jul 2024
The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1447403
- 978 views
Review
Published on 26 Jul 2024
Anti-inflammatory properties of polysaccharides from edible fungi on health-promotion: a review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1447677
- 1,005 views
Review
Published on 24 Jul 2024
Emerging roles of non-coding RNAs in fibroblast to myofibroblast transition and fibrotic diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1423045
- 942 views
Correction
Published on 23 Jul 2024
Corrigendum: Ginsenoside compound K attenuates ox-LDL-mediated macrophage inflammation and foam cell formation via autophagy induction and modulating NF-kB, p38, and JNK MAPK signaling
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1452605
- 686 views
Original Research
Published on 23 Jul 2024
The relationship between dexmedetomidine administration and prognosis in patients with sepsis-induced coagulopathy: a retrospective cohort study
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1414809
- 1,930 views
Review
Published on 17 Jul 2024
Pericytes: jack-of-all-trades in cancer-related inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426033
- 1,516 views
Correction
Published on 17 Jul 2024
Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418824
- 488 views
Review
Published on 12 Jul 2024
The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1410104
- 1,240 views